Evofem Biosciences Faces Merger and Credit Challenges
Company Announcements

Evofem Biosciences Faces Merger and Credit Challenges

Evofem Biosciences ( (EVFM) ) has issued an announcement.

Evofem Biosciences, Inc. has entered into support agreements with institutional investors to facilitate its merger with Aditxt, Inc., ensuring investor backing against any competing acquisition proposals. Concurrently, a forbearance agreement with its secured creditors has been terminated due to new default claims, affecting the company’s repayment agreements, including those with the U.S. Department of Health and Human Services.

For a thorough assessment of EVFM stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskEvofem Biosciences Gains Support for Aditxt Merger
TheFlyAditxt announces Evofem secures voting agreements with investors for merger
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App